EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: From January 2008...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Song Ee, Noh, Jae Myoung, Kim, You Jin, Lee, Han Sang, Cho, Jang Ho, Lim, Sung Won, Ahn, Yong Chan, Pyo, Hongryull, Choi, Yoon-La, Han, Joungho, Sun, Jong-Mu, Lee, Se Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473280/
https://www.ncbi.nlm.nih.gov/pubmed/29914238
http://dx.doi.org/10.4143/crt.2018.125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473280/
https://www.ncbi.nlm.nih.gov/pubmed/29914238
http://dx.doi.org/10.4143/crt.2018.125

Ejemplares similares